Lisata Therapeutics to Present at LD Micro Main Event XIX

BASKING RIDGE, N.J. (October 13, 2025)  – Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J.